N 15 Pill - green oval, 8mm
Pill with imprint N 15 is Green, Oval and has been identified as Morphine Sulfate Extended-Release 15 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for N 15
Morphine Sulfate Extended-Release
- Imprint
- N 15
- Strength
- 15 mg
- Color
- Green
- Size
- 8.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Zydus Pharmaceuticals (USA) Inc.
- National Drug Code (NDC)
- 68382-0903
- Inactive Ingredients
-
carnauba wax,
D&C Yellow No. 10,
FD&C Blue No. 1,
hypromelloses,
lactose monohydrate,
magnesium stearate,
polyethylene glycol,
polysorbate 80,
stearic acid,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "N 15"
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (364)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine Immediate-Release Tablets and Capsules
- Morphine Extended-Release Capsules
Other brands
MS Contin, Roxanol, Duramorph, Astramorph PF, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Duramorph, Astramorph PF, Kadian, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.